BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38836233)

  • 21. Organ Protection by Caloric Restriction Depends on Activation of the De Novo NAD+ Synthesis Pathway.
    Späth MR; Hoyer-Allo KJR; Seufert L; Höhne M; Lucas C; Bock T; Isermann L; Brodesser S; Lackmann JW; Kiefer K; Koehler FC; Bohl K; Ignarski M; Schiller P; Johnsen M; Kubacki T; Grundmann F; Benzing T; Trifunovic A; Krüger M; Schermer B; Burst V; Müller RU
    J Am Soc Nephrol; 2023 May; 34(5):772-792. PubMed ID: 36758124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MDM2 controls NRF2 antioxidant activity in prevention of diabetic kidney disease.
    Guo W; Tian D; Jia Y; Huang W; Jiang M; Wang J; Sun W; Wu H
    Biochim Biophys Acta Mol Cell Res; 2018 Aug; 1865(8):1034-1045. PubMed ID: 29704532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. L-NAME Administration Enhances Diabetic Kidney Disease Development in an STZ/NAD Rat Model.
    Corremans R; D'Haese PC; Vervaet BA; Verhulst A
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-135a regulates renal fibrosis in rats with diabetic kidney disease through the Notch pathway.
    Zhang LY; Wang Y; Yang YR; Shao JJ; Liang B
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1979-1987. PubMed ID: 32141566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD38 inhibition by apigenin ameliorates mitochondrial oxidative stress through restoration of the intracellular NAD
    Ogura Y; Kitada M; Xu J; Monno I; Koya D
    Aging (Albany NY); 2020 Jun; 12(12):11325-11336. PubMed ID: 32507768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex-specific alterations in NAD+ metabolism in 3xTg Alzheimer's disease mouse brain assessed by quantitative targeted LC-MS.
    van der Velpen V; Rosenberg N; Maillard V; Teav T; Chatton JY; Gallart-Ayala H; Ivanisevic J
    J Neurochem; 2021 Oct; 159(2):378-388. PubMed ID: 33829502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NAD
    Xu J; Kitada M; Koya D
    Front Med (Lausanne); 2021; 8():703076. PubMed ID: 34368195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complement C5a Induces Renal Injury in Diabetic Kidney Disease by Disrupting Mitochondrial Metabolic Agility.
    Tan SM; Ziemann M; Thallas-Bonke V; Snelson M; Kumar V; Laskowski A; Nguyen TV; Huynh K; Clarke MV; Libianto R; Baker ST; Skene A; Power DA; MacIsaac RJ; Henstridge DC; Wetsel RA; El-Osta A; Meikle PJ; Wilson SG; Forbes JM; Cooper ME; Ekinci EI; Woodruff TM; Coughlan MT
    Diabetes; 2020 Jan; 69(1):83-98. PubMed ID: 31624141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted deletion of nicotinamide adenine dinucleotide phosphate oxidase 4 from proximal tubules is dispensable for diabetic kidney disease development.
    Thallas-Bonke V; Tan SM; Lindblom RS; Snelson M; Granata C; Jha JC; Sourris KC; Laskowski A; Watson A; Tauc M; Rubera I; Zheng G; Shah AM; Harris DCH; Elbatreek MH; Kantharidis P; Cooper ME; Jandeleit-Dahm K; Coughlan MT
    Nephrol Dial Transplant; 2021 May; 36(6):988-997. PubMed ID: 33367789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pre-emptive Short-term Nicotinamide Mononucleotide Treatment in a Mouse Model of Diabetic Nephropathy.
    Yasuda I; Hasegawa K; Sakamaki Y; Muraoka H; Kawaguchi T; Kusahana E; Ono T; Kanda T; Tokuyama H; Wakino S; Itoh H
    J Am Soc Nephrol; 2021 Jun; 32(6):1355-1370. PubMed ID: 33795425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absence of the β1 subunit of AMP-activated protein kinase reduces myofibroblast infiltration of the kidneys in early diabetes.
    Choy SW; Fraser SA; Katerelos M; Galic S; Kemp BE; Mount PF; Power DA
    Int J Exp Pathol; 2019 Apr; 100(2):114-122. PubMed ID: 31025787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NADPH oxidase NOX1 is involved in activation of protein kinase C and premature senescence in early stage diabetic kidney.
    Zhu K; Kakehi T; Matsumoto M; Iwata K; Ibi M; Ohshima Y; Zhang J; Liu J; Wen X; Taye A; Fan C; Katsuyama M; Sharma K; Yabe-Nishimura C
    Free Radic Biol Med; 2015 Jun; 83():21-30. PubMed ID: 25701431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interplay between RNA-binding protein HuR and Nox4 as a novel therapeutic target in diabetic kidney disease.
    Shi Q; Lee DY; Féliers D; Abboud HE; Bhat MA; Gorin Y
    Mol Metab; 2020 Jun; 36():100968. PubMed ID: 32240965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of liraglutide on the Janus kinase/signal transducer and transcription activator (JAK/STAT) pathway in diabetic kidney disease in db/db mice and in cultured endothelial cells.
    Zitman-Gal T; Einbinder Y; Ohana M; Katzav A; Kartawy A; Benchetrit S
    J Diabetes; 2019 Aug; 11(8):656-664. PubMed ID: 30575282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FoxO1-mediated inhibition of STAT1 alleviates tubulointerstitial fibrosis and tubule apoptosis in diabetic kidney disease.
    Huang F; Wang Q; Guo F; Zhao Y; Ji L; An T; Song Y; Liu Y; He Y; Qin G
    EBioMedicine; 2019 Oct; 48():491-504. PubMed ID: 31629675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations in Protein Translation and Carboxylic Acid Catabolic Processes in Diabetic Kidney Disease.
    Collins KS; Eadon MT; Cheng YH; Barwinska D; Melo Ferreira R; McCarthy TW; Janosevic D; Syed F; Maier B; El-Achkar TM; Kelly KJ; Phillips CL; Hato T; Sutton TA; Dagher PC
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Podocyte-Specific Loss of Krüppel-Like Factor 6 Increases Mitochondrial Injury in Diabetic Kidney Disease.
    Horne SJ; Vasquez JM; Guo Y; Ly V; Piret SE; Leonardo AR; Ling J; Revelo MP; Bogenhagen D; Yang VW; He JC; Mallipattu SK
    Diabetes; 2018 Nov; 67(11):2420-2433. PubMed ID: 30115650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal hypertrophy in experimental diabetes. The activity of the 'de novo' and salvage pathways of purine [corrected] synthesis.
    Kunjara S; Beardsley SJ; Greenbaum AL
    Biochem J; 1988 Feb; 249(3):911-4. PubMed ID: 2451505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maresin 1 Alleviates Diabetic Kidney Disease via LGR6-Mediated cAMP-SOD2-ROS Pathway.
    Li X; Xu B; Wu J; Pu Y; Wan S; Zeng Y; Wang M; Luo L; Zhang F; Jiang Z; Xu Y
    Oxid Med Cell Longev; 2022; 2022():7177889. PubMed ID: 35498124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interplay between Akt and p38 MAPK pathways in the regulation of renal tubular cell apoptosis associated with diabetic nephropathy.
    Rane MJ; Song Y; Jin S; Barati MT; Wu R; Kausar H; Tan Y; Wang Y; Zhou G; Klein JB; Li X; Cai L
    Am J Physiol Renal Physiol; 2010 Jan; 298(1):F49-61. PubMed ID: 19726550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.